241 related articles for article (PubMed ID: 31195068)
1. Genetic toxicology in silico protocol.
Hasselgren C; Ahlberg E; Akahori Y; Amberg A; Anger LT; Atienzar F; Auerbach S; Beilke L; Bellion P; Benigni R; Bercu J; Booth ED; Bower D; Brigo A; Cammerer Z; Cronin MTD; Crooks I; Cross KP; Custer L; Dobo K; Doktorova T; Faulkner D; Ford KA; Fortin MC; Frericks M; Gad-McDonald SE; Gellatly N; Gerets H; Gervais V; Glowienke S; Van Gompel J; Harvey JS; Hillegass J; Honma M; Hsieh JH; Hsu CW; Barton-Maclaren TS; Johnson C; Jolly R; Jones D; Kemper R; Kenyon MO; Kruhlak NL; Kulkarni SA; Kümmerer K; Leavitt P; Masten S; Miller S; Moudgal C; Muster W; Paulino A; Lo Piparo E; Powley M; Quigley DP; Reddy MV; Richarz AN; Schilter B; Snyder RD; Stavitskaya L; Stidl R; Szabo DT; Teasdale A; Tice RR; Trejo-Martin A; Vuorinen A; Wall BA; Watts P; White AT; Wichard J; Witt KL; Woolley A; Woolley D; Zwickl C; Myatt GJ
Regul Toxicol Pharmacol; 2019 Oct; 107():104403. PubMed ID: 31195068
[TBL] [Abstract][Full Text] [Related]
2. In silico toxicology protocols.
Myatt GJ; Ahlberg E; Akahori Y; Allen D; Amberg A; Anger LT; Aptula A; Auerbach S; Beilke L; Bellion P; Benigni R; Bercu J; Booth ED; Bower D; Brigo A; Burden N; Cammerer Z; Cronin MTD; Cross KP; Custer L; Dettwiler M; Dobo K; Ford KA; Fortin MC; Gad-McDonald SE; Gellatly N; Gervais V; Glover KP; Glowienke S; Van Gompel J; Gutsell S; Hardy B; Harvey JS; Hillegass J; Honma M; Hsieh JH; Hsu CW; Hughes K; Johnson C; Jolly R; Jones D; Kemper R; Kenyon MO; Kim MT; Kruhlak NL; Kulkarni SA; Kümmerer K; Leavitt P; Majer B; Masten S; Miller S; Moser J; Mumtaz M; Muster W; Neilson L; Oprea TI; Patlewicz G; Paulino A; Lo Piparo E; Powley M; Quigley DP; Reddy MV; Richarz AN; Ruiz P; Schilter B; Serafimova R; Simpson W; Stavitskaya L; Stidl R; Suarez-Rodriguez D; Szabo DT; Teasdale A; Trejo-Martin A; Valentin JP; Vuorinen A; Wall BA; Watts P; White AT; Wichard J; Witt KL; Woolley A; Woolley D; Zwickl C; Hasselgren C
Regul Toxicol Pharmacol; 2018 Jul; 96():1-17. PubMed ID: 29678766
[TBL] [Abstract][Full Text] [Related]
3. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
Amberg A; Beilke L; Bercu J; Bower D; Brigo A; Cross KP; Custer L; Dobo K; Dowdy E; Ford KA; Glowienke S; Van Gompel J; Harvey J; Hasselgren C; Honma M; Jolly R; Kemper R; Kenyon M; Kruhlak N; Leavitt P; Miller S; Muster W; Nicolette J; Plaper A; Powley M; Quigley DP; Reddy MV; Spirkl HP; Stavitskaya L; Teasdale A; Weiner S; Welch DS; White A; Wichard J; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():13-24. PubMed ID: 26877192
[TBL] [Abstract][Full Text] [Related]
4. Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.
Landry C; Kim MT; Kruhlak NL; Cross KP; Saiakhov R; Chakravarti S; Stavitskaya L
Regul Toxicol Pharmacol; 2019 Dec; 109():104488. PubMed ID: 31586682
[TBL] [Abstract][Full Text] [Related]
5. In Silico Approaches in Predictive Genetic Toxicology.
Sinha M; Dhawan A; Parthasarathi R
Methods Mol Biol; 2019; 2031():351-373. PubMed ID: 31473971
[TBL] [Abstract][Full Text] [Related]
6.
Tice RR; Bassan A; Amberg A; Anger LT; Beal MA; Bellion P; Benigni R; Birmingham J; Brigo A; Bringezu F; Ceriani L; Crooks I; Cross K; Elespuru R; Faulkner DM; Fortin MC; Fowler P; Frericks M; Gerets HHJ; Jahnke GD; Jones DR; Kruhlak NL; Lo Piparo E; Lopez-Belmonte J; Luniwal A; Luu A; Madia F; Manganelli S; Manickam B; Mestres J; Mihalchik-Burhans AL; Neilson L; Pandiri A; Pavan M; Rider CV; Rooney JP; Trejo-Martin A; Watanabe-Sailor KH; White AT; Woolley D; Myatt GJ
Comput Toxicol; 2021 Nov; 20():. PubMed ID: 35368437
[TBL] [Abstract][Full Text] [Related]
7. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
[TBL] [Abstract][Full Text] [Related]
8. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.
Sutter A; Amberg A; Boyer S; Brigo A; Contrera JF; Custer LL; Dobo KL; Gervais V; Glowienke S; van Gompel J; Greene N; Muster W; Nicolette J; Reddy MV; Thybaud V; Vock E; White AT; Müller L
Regul Toxicol Pharmacol; 2013 Oct; 67(1):39-52. PubMed ID: 23669331
[TBL] [Abstract][Full Text] [Related]
9. Assessing the impact of expert knowledge on ICH M7 (Q)SAR predictions. Is expert review still needed?
Jayasekara PS; Skanchy SK; Kim MT; Kumaran G; Mugabe BE; Woodard LE; Yang J; Zych AJ; Kruhlak NL
Regul Toxicol Pharmacol; 2021 Oct; 125():105006. PubMed ID: 34273441
[TBL] [Abstract][Full Text] [Related]
10. Skin sensitization in silico protocol.
Johnson C; Ahlberg E; Anger LT; Beilke L; Benigni R; Bercu J; Bobst S; Bower D; Brigo A; Campbell S; Cronin MTD; Crooks I; Cross KP; Doktorova T; Exner T; Faulkner D; Fearon IM; Fehr M; Gad SC; Gervais V; Giddings A; Glowienke S; Hardy B; Hasselgren C; Hillegass J; Jolly R; Krupp E; Lomnitski L; Magby J; Mestres J; Milchak L; Miller S; Muster W; Neilson L; Parakhia R; Parenty A; Parris P; Paulino A; Paulino AT; Roberts DW; Schlecker H; Stidl R; Suarez-Rodrigez D; Szabo DT; Tice RR; Urbisch D; Vuorinen A; Wall B; Weiler T; White AT; Whritenour J; Wichard J; Woolley D; Zwickl C; Myatt GJ
Regul Toxicol Pharmacol; 2020 Oct; 116():104688. PubMed ID: 32621976
[TBL] [Abstract][Full Text] [Related]
11. Use of In Silico Methods for Regulatory Toxicological Assessment of Pharmaceutical Impurities.
Kovarich S; Cappelli CI
Methods Mol Biol; 2022; 2425():537-560. PubMed ID: 35188646
[TBL] [Abstract][Full Text] [Related]
12. The Consultancy Activity on In Silico Models for Genotoxic Prediction of Pharmaceutical Impurities.
Pavan M; Kovarich S; Bassan A; Broccardo L; Yang C; Fioravanzo E
Methods Mol Biol; 2016; 1425():511-29. PubMed ID: 27311479
[TBL] [Abstract][Full Text] [Related]
13. Establishing best practise in the application of expert review of mutagenicity under ICH M7.
Barber C; Amberg A; Custer L; Dobo KL; Glowienke S; Van Gompel J; Gutsell S; Harvey J; Honma M; Kenyon MO; Kruhlak N; Muster W; Stavitskaya L; Teasdale A; Vessey J; Wichard J
Regul Toxicol Pharmacol; 2015 Oct; 73(1):367-77. PubMed ID: 26248005
[TBL] [Abstract][Full Text] [Related]
14. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.
Ahlberg E; Amberg A; Beilke LD; Bower D; Cross KP; Custer L; Ford KA; Van Gompel J; Harvey J; Honma M; Jolly R; Joossens E; Kemper RA; Kenyon M; Kruhlak N; Kuhnke L; Leavitt P; Naven R; Neilan C; Quigley DP; Shuey D; Spirkl HP; Stavitskaya L; Teasdale A; White A; Wichard J; Zwickl C; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():1-12. PubMed ID: 26879463
[TBL] [Abstract][Full Text] [Related]
15. In silico prediction of genotoxicity.
Wichard JD
Food Chem Toxicol; 2017 Aug; 106(Pt B):595-599. PubMed ID: 27979779
[TBL] [Abstract][Full Text] [Related]
16. Carbamates and ICH M7 classification: Making use of expert knowledge.
Hemingway R; Fowkes A; Williams RV
Regul Toxicol Pharmacol; 2017 Jun; 86():392-401. PubMed ID: 28385577
[TBL] [Abstract][Full Text] [Related]
17. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
18. A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies.
Barber C; Antonucci V; Baumann JC; Brown R; Covey-Crump E; Elder D; Elliott E; Fennell JW; Gallou F; Ide ND; Jordine G; Kallemeyn JM; Lauwers D; Looker AR; Lovelle LE; McLaughlin M; Molzahn R; Ott M; Schils D; Oestrich RS; Stevenson N; Talavera P; Teasdale A; Urquhart MW; Varie DL; Welch D
Regul Toxicol Pharmacol; 2017 Nov; 90():22-28. PubMed ID: 28822875
[TBL] [Abstract][Full Text] [Related]
19. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
[TBL] [Abstract][Full Text] [Related]
20. A problem formulation framework for the application of in silico toxicology methods in chemical risk assessment.
Achar J; Cronin MTD; Firman JW; Öberg G
Arch Toxicol; 2024 Jun; 98(6):1727-1740. PubMed ID: 38555325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
